# Testing the Combination of Inotuzumab Ozogamicin and Lower Dose Chemotherapy Compared to Usual Chemotherapy for Adults With B-Cell Acute Lymphoblastic Leukemia or B-Cell Lymphoblastic Lymphoma

> **NCT05303792** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Alliance for Clinical Trials in Oncology** · enrollment: 68 (actual)

## Conditions studied

- B Acute Lymphoblastic Leukemia
- B Lymphoblastic Lymphoma

## Interventions

- **DRUG:** Cyclophosphamide
- **DRUG:** Vincristine
- **DRUG:** Dexamethasone
- **BIOLOGICAL:** Inotuzumab Ozogamicin
- **DRUG:** Methotrexate
- **DRUG:** Cytarabine
- **DRUG:** Methylprednisolone
- **BIOLOGICAL:** Rituximab
- **DRUG:** Prednisone
- **DRUG:** Mercaptopurine
- **DRUG:** Doxorubicin

## Key facts

- **NCT ID:** NCT05303792
- **Lead sponsor:** Alliance for Clinical Trials in Oncology
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-06-09
- **Primary completion:** 2027-04-01
- **Final completion:** 2029-05
- **Target enrollment:** 68 (ACTUAL)
- **Last updated:** 2026-04-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05303792

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05303792, "Testing the Combination of Inotuzumab Ozogamicin and Lower Dose Chemotherapy Compared to Usual Chemotherapy for Adults With B-Cell Acute Lymphoblastic Leukemia or B-Cell Lymphoblastic Lymphoma". Retrieved via AI Analytics 2026-08-01 from https://api.ai-analytics.org/clinical/NCT05303792. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*